Sarepta Therapeutics (SRPT) Non-Current Deffered Revenue (2020 - 2026)
Sarepta Therapeutics' Non-Current Deffered Revenue was $110.13 million in Q2 2026, down 19.2% from the prior quarter.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Deffered Revenue at Sarepta Therapeutics came in at $83.91 million, down 74.2% from FY2024.
- Non-Current Deffered Revenue has now declined for five consecutive years, with a five-year compound annual growth rate of -33.9% (FY2020 to FY2025).
- In earlier years, Non-Current Deffered Revenue was $325 million in FY2024 (-25.6%), $437 million in FY2023 (-9.9%), $485 million in FY2022 (-15.5%) and $574.24 million in FY2021 (-13.5%).
- Quarterly Non-Current Deffered Revenue has moved between $83.91 million (Q4 2025) and $596.74 million (Q3 2021) over five years.
- The year-over-year decline in Non-Current Deffered Revenue has ranged between 0.0% (Q1 2025) and 74.2% (Q4 2025) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Sarepta Therapeutics | 1.92 Bn | -1.31 Bn | 251.87 Mn | 110.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 110.13 Mn |
| Mar 31, 2026 | 136.35 Mn |
| Dec 31, 2025 | 83.91 Mn |
| Mar 31, 2025 | 325.00 Mn |
| Dec 31, 2024 | 325.00 Mn |
| Sep 30, 2024 | 325.00 Mn |
| Jun 30, 2024 | 325.00 Mn |
| Mar 31, 2024 | 325.00 Mn |
| Dec 31, 2023 | 437.00 Mn |
| Sep 30, 2023 | 485.00 Mn |
| Jun 30, 2023 | 485.00 Mn |
| Mar 31, 2023 | 485.00 Mn |
| Dec 31, 2022 | 485.00 Mn |
| Sep 30, 2022 | 507.49 Mn |
| Jun 30, 2022 | 529.99 Mn |
| Mar 31, 2022 | 552.24 Mn |
| Dec 31, 2021 | 574.24 Mn |
| Sep 30, 2021 | 596.74 Mn |
| Jun 30, 2021 | 619.23 Mn |
| Mar 31, 2021 | 641.48 Mn |
API Access
Sarepta Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SRPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();